Day 2 Highlights - ACC.19

00:08:32

3 years 14 Views

Embed (Iframe):

<div class="embed-responsive embed-responsive-16by9"><iframe width="640" height="360" style="max-width: 100%;max-height: 100%; border:none;" src="https://cardiologytalk.com/channel/_5feba5631406a/videoEmbed/45/day-2-highlights-%7C-acc.19?modestbranding=1&showinfo=1&autoplay=&controls=1&loop=&mute=&t=0&objectFit=" frameborder="0" allowfullscreen="allowfullscreen" allow="autoplay" scrolling="no">iFrame is not supported!</iframe></div>

Embed (Object):

<div class="embed-responsive embed-responsive-16by9"><object width="640" height="360"><param name="movie" value="https://cardiologytalk.com/channel/_5feba5631406a/videoEmbed/45/day-2-highlights-%7C-acc.19?modestbranding=1&showinfo=1&autoplay=&controls=1&loop=&mute=&t=0&objectFit="></param><param name="allowFullScreen" value="true"></param><param name="allowscriptaccess" value="always"></param><embed src="https://cardiologytalk.com/channel/_5feba5631406a/videoEmbed/45/day-2-highlights-%7C-acc.19?modestbranding=1&showinfo=1&autoplay=&controls=1&loop=&mute=&t=0&objectFit=" allowscriptaccess="always" allowfullscreen="true" width="640" height="360"></embed></object></div>

Link (HTML):

<a href="https://cardiologytalk.com/channel/_5feba5631406a/video/45"><img src="https://cardiologytalk.com/view/img/video-placeholder-gray-portrait.webp?cache=1693571558_1693571558">Day 2 Highlights | ACC.19</a>

Link (BBCode):

[url=https://cardiologytalk.com/channel/_5feba5631406a/video/45][img]https://cardiologytalk.com/view/img/video-placeholder-gray-portrait.webp?cache=1693571558_1693571558[/img]Day 2 Highlights | ACC.19[/url]

Sign in now!

Permanent Link

URL Friendly (SEO)

Current Time (SEO)

Category:

Acute Coronary Syndromes

Description:

Drs. Kim Eagle, Deepak Bhatt, and Peter Block discuss TAVR vs. SAVR in low-risk patients (PARTNER 3 and Evolut Low Risk - 00:39); safety evaluation of apixaban vs. vitamin K antagonist and aspirin vs. placebo in patients with AFib and ACS and/or PCI (AUGUSTUS - 2:55); partial oral treatment of left-sided infectious endocarditis (POET - 4:16); and a multicenter study of MagLev technology in patients undergoing mechanical circulatory support therapy with HeartMate 3 (MOMENTUM 3 - 6:25). Visit http://www.acc.org/ACC19 for full meeting coverage.